SynthesisJournal of robotic surgery2026
Meta-analysis of perioperative and renal functional outcomes of Robot-Assisted Partial Ureterectomy (RASU) versus complete Nephroureterectomy (RARNU) for upper tract urothelial tumors.
Synthesis in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This meta-analysis investigated the comparative effectiveness of two robotic surgical interventions—the kidney-sparing approach (segmental ureterectomy) was compared against the traditional radical procedure—in treating Tumor of the Ureter, with a focus on perioperative results and renal function preservation. Following the PRISMA guidelines, a systematic literature search was performed across multiple electronic databases was conducted in databases. A meta-analysis was performed on the extracted data, evaluating outcomes such as surgical time, volume of intraoperative bleeding, postoperative complications, duration of hospitalization, glomerular filtration rate within 3 months, incidence of positive margins, cases of recurrence, postoperative tumor grade, number of lymph node dissections, proportion of ≥ pT2 stage, and Lymph node tumor burden. Operative duration, volume of intraoperative bleeding, incidence of postoperative morbidity, and the 3-month glomerular filtration rate were designated as the primary outcome measures. Four studies involving 683 patients were included. We identified a total of 1045 records through our literature search. After eliminating overlapping publications and screening, 4 studies (3 retrospective and 1 prospective) involving 683 patients (the study population comprised 683 patients, with 108 allocated to the RASU cohort and 575 to the RARNU cohort.) were finally included. Analysis of demographic and clinical features, such as age, sex, BMI, and renal function prior to surgery, showed no highly significant disparities between the cohorts. except for with 3 months eGFR (P = 0.02), Post operative complications (P = 0.03).
Indexed as
Identifiers
41844916What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.